Call for Abstract
Scientific Program
International Conference on Thrombosis and Hemostasis, will be organized around the theme “Advances in clinical diagnosis and therapeutic interventions”
Thrombosis-2015 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Thrombosis-2015
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
- Track 1-1Aging and Thrombosis
- Track 1-2Arterial Thrombosis
- Track 1-3Pulmonary embolism
- Track 1-4Aging and Thrombosis
- Track 1-5Coronary thrombosis
- Track 1-6Stent thrombosis
- Track 1-7Portal vein thrombosis
- Track 2-1Venous sinus thrombosis
- Track 2-2Saggital sinu thrombosis
- Track 2-3Dural sinus thrombosis
- Track 2-4Intracranial venous Thrombosis
- Track 2-5Transvers sinus thrombosis
- Track 3-1Blood clot
- Track 3-2External haemaroids
- Track 3-3Venous stasis
- Track 3-4 Venous insufficiency
- Track 3-5Venous thrombosis
- Track 3-6Deep vein thrombosis
- Track 4-1varicose vein
- Track 4-2vericose vein pain management
- Track 4-3vericose vein surgery
- Track 4-4Advances in vericose vein treatment
- Track 4-5Coagulation and vascular Patency
- Track 4-6Peripheral artery disease
- Track 5-1Autoimmune diseases and thrombosis
- Track 5-2Cancer and thrombosis
- Track 5-3 Dysfunctional angiogenesis
- Track 5-4Hemostasis, pregnancy and obstetrics
- Track 5-5Pediatrics and thrombosis
- Track 6-1Diabetic vascular complications
- Track 6-2Metabolic syndrome, diabetes and thrombosis
- Track 6-3Nutrition, obesity and hemostasis
- Track 6-4Management of venous and arterial thrombosis in children
- Track 6-5Optimal duration of prophylaxis of postoperative venous thrombosis
- Track 6-6Fibrinolysis and angiogenesis in gynecological pathology
- Track 7-1Leucocytes and hemostasis
- Track 7-2Micro biome and thrombosis
- Track 7-3Infection, Inflammation and Thrombotic Events
- Track 7-4Thrombosis as an intravascular effector of innate immunity
- Track 7-5complex problems in blood diseases and transfusion medicine
- Track 8-1Experimental thrombosis
- Track 8-2Animal models of thrombosis
 anticoagulants
- Track 8-3Novel agents and test principles
- Track 8-4 Platelet function testing
- Track 8-5Reducing the burden of thrombosis in interventional cardiology
- Track 9-1Hemorrhagic diathesis
- Track 9-2 Von will brand factor
- Track 9-3Bleeding disorders
- Track 9-4Antithrombotic therpay for trial fibrilation
- Track 9-5 Fibrinogen and thrombin
- Track 10-1Thrombocytopenia
- Track 10-2Platelet aspects
- Track 10-3Platelet concentrates and transfusion medicine
- Track 10-4The role of platelets in vascular integrity in the context of inflammation
- Track 10-5New modulators of platelet activation
- Track 11-1Thrombosis diagnosis
- Track 11-2 Antiplatelet agents
- Track 11-3Perioperative bridging
- Track 11-4 Pharmacogenomics and drug Interactioni
- Track 11-5Role of antibodies in blood coagulation
- Track 11-6The agnostic approach in posttraumatic 
coagulopathy
- Track 12-1Clinical and applied thrombosis
- Track 12-2Pediatric hemostasis and thrombosis
- Track 12-3Genetics of thrombosis: from mice to humans
- Track 12-4 Thrombosis genetic disorders
- Track 12-5Laboratory testing for thrombophilia in pediatric patients
- Track 13-1 Blood transfusion and allergic reaction
- Track 13-2Sclerotherapy
- Track 13-3Transmission of diseases and Infection Via blood transfusion
- Track 13-4Complex problems in blood diseases and transfusion medicine
- Track 13-5Transfusion Medicine await Translation into Clinical Research
- Track 13-6Sickle cell disease Immunopathology
- Track 14-1Venous thromboembolism
- Track 14-2Thromboembolic disease
- Track 14-3Thrombosis hemarrhoid
- Track 14-4Thrombectomy
- Track 14-5Venous thrombectomy
- Track 14-6Thrombolysis and thrombectomy